Literature DB >> 11070525

Limitations in using existing alcohol treatment trials to develop practice guidelines.

J W Finney1.   

Abstract

In recent years, substantial efforts have been made to identify "best practices" and develop comprehensive practice guidelines for the treatment of various psychiatric disorders and medical conditions, based on systematic, often quantitative reviews of the existing intervention research. There probably are more than 300 comparative treatment trials that have been conducted in the alcohol field. With this large body of research, one might think the development of alcohol treatment guidelines would be a straightforward task. Unfortunately, that is not the case. Four problems are discussed with the "box-score" reviews that have been conducted thus far to identify effective alcohol treatment modalities. At least two of these problems are fundamental barriers to determining the relative efficacy or effectiveness of alcohol treatment modalities even in "meta-analyses" with "effect sizes". These impediments are discussed, as is how future alcohol treatment trials could be conducted so that their findings would more readily inform practice guidelines.

Entities:  

Mesh:

Year:  2000        PMID: 11070525     DOI: 10.1046/j.1360-0443.2000.951014914.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  4 in total

1.  'The human prerogative': a critical analysis of evidence-based and other paradigms of care in substance abuse treatment.

Authors:  Eric Broekaert; Mieke Autrique; Wouter Vanderplasschen; Kathy Colpaert
Journal:  Psychiatr Q       Date:  2010-09

2.  Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT).

Authors: 
Journal:  BMJ       Date:  2005-09-10

Review 3.  Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria.

Authors:  Brittany B Dennis; Pavel S Roshanov; Leen Naji; Monica Bawor; James Paul; Carolyn Plater; Guillaume Pare; Andrew Worster; Michael Varenbut; Jeff Daiter; David C Marsh; Dipika Desai; Zainab Samaan; Lehana Thabane
Journal:  Trials       Date:  2015-10-21       Impact factor: 2.279

4.  Compared with what? An analysis of control-group types in Cochrane and Campbell reviews of psychosocial treatment efficacy with substance use disorders.

Authors:  Patrik Karlsson; Anders Bergmark
Journal:  Addiction       Date:  2015-01-15       Impact factor: 6.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.